Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4843
Peer-review started: December 11, 2021
First decision: January 26, 2022
Revised: February 3, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: May 26, 2022
Processing time: 163 Days and 22.5 Hours
Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and long-lasting side effect caused by various anticancer agents that damage sensory, motor and autonomic nerves. It can cause maladaptive behaviors, including disease severity, anxiety, depression, sleep disorders, falls, and social impairment. These disorders have physical, psychological and social effects on patients and can seriously influence their quality of life.
To investigate the current situation of psychosocial adaptation to the disease and its influencing factor in patients with CIPN.
A convenience sampling method was used to select 233 patients with CIPN in our hospital from February to August 2021. In addition, a cross-sectional survey was conducted using a sociodemographic questionnaire, the Self-Report Psychosocial Adjustment to Illness Scale, and the European Organisation for the Research and Treatment of Cancer Quality of Life CIPN20 (QLQ-CIPN20). Factors influencing psychosocial adaptation in patients with CIPN were analyzed by t-test or one-way analysis of variance, correlation analysis, multiple stepwise regression analysis, and structural equation models.
The psychosocial adaptation score of patients with CIPN was 52.51 ± 13.18. Multivariate analysis showed that autonomic nerves, tumor stage, motor nerves, education level, availability of caregivers, semi-retirement status, CIPN grade were independent risk factors for patients with CIPN (P < 0.05). Structural equation models showed that QLQ-CIPN20 mediated the relationship between CIPN grade, tumor stage, and psychosocial adaptation.
Patients with CIPN have poor psychosocial adaptation and are affected by a variety of physiological, psychological, and social factors. Patients’ adaptive responses should be assessed, and targeted interventions implemented.
Core Tip: The incidence of chemotherapy-induced peripheral neuropathy (CIPN) is approximately 47% after 6 years of treatment, which severely affects the level of patient adaptation. Most studies have focused on interventions to alleviate the symptoms of neurotoxicity in patients, but there has been less focus on psychosocial adaptation. In this study, we investigated the psychosocial adaptation of 233 patients with CIPN to analyze the factors influencing their psychosocial adaptation.